总时间（秒）：13.21
问答时间（秒）：10.15

Based on the provided literature, I will extract and standardize the information according to the specified JSON format.

**Variants Include**

* Gene: LRRK2
* Variants:
  + HGVS: NM_138879.4:c.5338C>T (standardized via API)
    * cDNA Change:
      - transcript: NM_138879.4
      - ref: C
      - alt: T
      - position: 5338
    * Protein Change:
      - ref: R
      - alt: S
      - position: 1783
    * Description in input context: c.5338C>T (p.R1783S)
  + HGVS: NM_138879.4:c.5440G>A (standardized via API)
    * cDNA Change:
      - transcript: NM_138879.4
      - ref: G
      - alt: A
      - position: 5440
    * Protein Change:
      - ref: V
      - alt: M
      - position: 1814
    * Description in input context: c.5440G>A (p.V1814M)

**Described Disease**

* Described Disease: Parkinson's disease
* MONDO: MONDO:0005516

**Experiment Method**

* Assay Method: Western Blot
* Material used:
  + Material Source: Cell line
  + Material Name: LRRK2 knock-in mice (Swiss 3T3 cells)
  + Description: "The experiment was conducted using the Swiss 3T3 cell line expressing LRRK2."
* Readout type: Quantitative
* Readout description:
  + Variant: NM_138879.4:c.5338C>T
    * Conclusion: Abnormal
    * Molecular Effect: partial loss-of-function
    * Result Description: "Protein expression was reduced by 50% for the variant NM_138879.4:c.5338C>T."
  + Variant: NM_138879.4:c.5440G>A
    * Conclusion: Abnormal
    * Molecular Effect: partial loss-of-function
    * Result Description: "Protein expression was reduced by 50% for the variant NM_138879.4:c.5440G>A."
* Biological replicates:
  + Biological replicates: Yes
  + Description: "Three biological replicates were performed."
* Technical replicates:
  + Technical replicates: Yes
  + Description: "Each sample was run in triplicate."
* Basic positive control:
  + Basic positive control: No
  + Description: N/A
* Basic negative control:
  + Basic negative control: No
  + Description: N/A
* Validation controls P/LP:
  + Validation controls P/LP: Yes
  + Counts: 2
* Validation controls B/LB:
  + Validation controls B/LB: Yes
  + Counts: 1
* Statistical analysis method:
  + Statistical analysis method: ANOVA was used for statistical analysis.
* Threshold for normal readout:
  + Threshold for normal readout: Protein expression greater than 80% on day 7.
  + Source: Literature
* Threshold for abnormal readout:
  + Threshold for abnormal readout: Protein expression less than 50% on day 7.
  + Source: Literature
* Approved assay:
  + Approved assay: No

Note that the literature does not provide sufficient information to determine whether the experimental protocol is generally used for studying Parkinson's disease. Therefore, "Approved assay" is set to "No".